Greenwich LifeSciences (GLSI) EV/Sales: History & Chart

Greenwich LifeSciences, Inc.(GLSI)

Biotechnology · Stafford, TX

$16.54-0.37 (-2.18%)

Delayed quote: Oct 6, 2026, 1:07 PM EDT

About Greenwich LifeSciences, Inc.

Greenwich LifeSciences, Inc. functions as a clinical-stage biopharmaceutical company, dedicated to developing innovative cancer immunotherapies. These treatments are primarily focused on breast cancer and other HER2/neu-positive malignancies. Its flagship therapeutic candidate is GP2, an immunotherapy which has successfully completed its Phase IIb clinical trials. This drug is designed to prevent the recurrence of breast cancer in patients who have already undergone surgical removal of the tumor. Founded in 2006 and based in Stafford, Texas, the company was formerly known as Norwell, Inc. until it rebranded to Greenwich LifeSciences, Inc. in March 2018.

Stafford, TX

13 employees

greenwichlifesciences.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Snehal S. Patel

View full financials

NAME	MARKET CAP	EV/SALES RATIO	TTM	3Y	5Y
Greenwich LifeSciences, Inc. (GLSI)	$242.80M	N/A	N/A	N/A	N/A
Lifecore Biomedical, Inc. (LFCR)vs ›	$242.50M	N/A	2.84x	2.61x	2.12x
Q32 Bio Inc. (QTTB)vs ›	$242.28M	2.63x	1.74x	7.11x	12.70x
Quantum-Si incorporated (QSI)vs ›	$246.31M	140.75x	82.98x	104.71x	179.48x
Nautilus Biotechnolgy, Inc. (NAUT)vs ›	$240.70M	1343.96x	755.80x	755.80x	755.80x
Galectin Therapeutics Inc. (GALT)vs ›	$241.04M	N/A	N/A	N/A	N/A
CAMP4 Therapeutics Corporation (CAMP)vs ›	$239.72M	36.76x	25.87x	23.90x	23.90x
InflaRx N.V. (IFRX)vs ›	$237.23M	N/A	1627.36x	1007.98x	1007.98x
Century Therapeutics, Inc. (IPSC)vs ›	$248.98M	N/A	0.88x	37.95x	73.84x
Sol-Gel Technologies Ltd. (SLGL)vs ›	$249.91M	130.37x	22.52x	45.89x	86.02x

NAME

MARKET CAP

EV/SALES RATIO

TTM

Greenwich LifeSciences, Inc. (GLSI)

$242.80M

N/A

Lifecore Biomedical, Inc. (LFCR)vs ›

$242.50M

N/A

2.84x

2.61x